{"news_desk": "Business", "print_page": "1", "section_name": "Business Day", "subsection_name": null, "byline": {"contributor": "Katie Benner contributed reporting.", "original": "By REED ABELSON", "person": [{"rank": 1, "role": "reported", "firstname": "Reed", "organization": "", "lastname": "ABELSON"}]}, "abstract": "Board members and investors in Theranos await announcement of management changes from founder and chief executive Elizabeth Holmes amid criminal investigation and persistent questions about whether core blood-testing technology works; insiders acknowledge that they have little leverage to effect change, underscoring peril of investing in firms where founder like Holmes exerts complete control. ", "type_of_material": "News", "word_count": "1236", "lead_paragraph": "Under criminal investigation and with skepticism about its core technology rising, a onetime Silicon Valley favorite\u2019s future is largely up to its founder, Elizabeth Holmes.", "pub_date": "2016-04-25T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Theranos\u2019s Fate Rests With a Founder Who Answers Only to Herself", "print_headline": "Theranos\u2019s Fate Rests With a Founder Who Has to Answer Only to Herself"}, "snippet": "Under criminal investigation and with skepticism about its core technology rising, a onetime Silicon Valley favorite\u2019s future is largely up to its founder, Elizabeth Holmes.", "multimedia": [{"height": 126, "url": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 400, "url": "images/2016/04/25/business/25theranos-web/25theranos-web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "400", "xlarge": "images/2016/04/25/business/25theranos-web/25theranos-web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/04/25/business/25theranos-web/25theranos-web-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/04/25/business/theranoss-fate-rests-with-afounder-who-answers-only-to-herself.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Theranos Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Holmes, Elizabeth (1984- )", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Tests (Medical)", "name": "subject"}, {"rank": "4", "is_major": "Y", "value": "Blood", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Boies, David", "name": "persons"}, {"rank": "6", "is_major": "N", "value": "Centers for Medicare and Medicaid Services", "name": "organizations"}, {"rank": "7", "is_major": "N", "value": "Securities and Exchange Commission", "name": "organizations"}], "blog": [], "_id": "571d5e9538f0d8550bf1a660", "source": "The New York Times"}